These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38993368)
1. The Impact of the COVID-19 Pandemic on Bladder Cancer Care in the Netherlands. van Hoogstraten LMC; Kiemeney LA; Meijer RP; van Leenders GJLH; Vanneste BGL; Incrocci L; Smilde TJ; Siesling S; Witjes JA; Aben KKH; Bladder Cancer; 2022; 8(2):139-154. PubMed ID: 38993368 [TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands. Deukeren DV; Heesterman BL; Roelofs L; Kiemeney LA; Witjes JA; Smilde TJ; Leenders GJLHV; Incrocci L; Vanneste BGL; Meijer RP; Siesling S; Bezooijen BPJV; Aben KKH; Cancer Treat Res Commun; 2022; 31():100553. PubMed ID: 35421819 [TBL] [Abstract][Full Text] [Related]
3. The impact of the COVID-19 pandemic on renal cancer care. Yildirim H; Bins AD; van den Hurk C; van Moorselaar RJA; van Oijen MGH; Bex A; Zondervan PJ; Aben KKH World J Urol; 2024 Apr; 42(1):231. PubMed ID: 38613582 [TBL] [Abstract][Full Text] [Related]
4. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis. Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102 [TBL] [Abstract][Full Text] [Related]
5. Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry. Richters A; Leliveld AM; Goossens-Laan CA; Aben KKH; Özdemir BC World J Urol; 2022 Sep; 40(9):2275-2281. PubMed ID: 35778577 [TBL] [Abstract][Full Text] [Related]
6. Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands. Oymans EJ; de Kroon CD; Bart J; Nijman HW; van der Aa MA Cancer Epidemiol; 2023 Aug; 85():102405. PubMed ID: 37356263 [TBL] [Abstract][Full Text] [Related]
7. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands. Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289 [TBL] [Abstract][Full Text] [Related]
8. Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy: a nationwide study of 5417 patients. van Hoogstraten LMC; van Gennep EJ; Kiemeney LALM; Witjes JA; Voskuilen CS; Deelen M; Mertens LS; Meijer RP; Boormans JL; Robbrecht DGJ; Beerepoot LV; Verhoeven RHA; Ripping TM; ; van Rhijn BWG; Aben KKH; Hermans TJN World J Urol; 2022 Jan; 40(1):111-118. PubMed ID: 34585294 [TBL] [Abstract][Full Text] [Related]
9. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702 [TBL] [Abstract][Full Text] [Related]
10. The Impact of the COVID Pandemic on the Incidence of Presentations with Cancer-Related Symptoms in Primary Care. Grant MP; Helsper CW; Stellato R; van Erp N; van Asselt KM; Slottje P; Muris J; Brandenbarg D; de Wit NJ; van Gils CH Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358772 [No Abstract] [Full Text] [Related]
11. Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer. Ripping TM; Witjes JA; Meijer RP; van Rhijn BWG; Oddens JR; Goossens-Laan CA; Mulder SF; van Moorselaar RJA; Kiemeney LA; Aben KKH Urol Oncol; 2020 Dec; 38(12):935.e9-935.e16. PubMed ID: 32917503 [TBL] [Abstract][Full Text] [Related]
12. The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy. Murasawa H; Koie T; Ohyama C; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Iwabuchi I; Ogasawara M; Kawaguchi T Int J Clin Oncol; 2017 Feb; 22(1):159-165. PubMed ID: 27534866 [TBL] [Abstract][Full Text] [Related]
13. Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship. Hensley PJ; Duan Z; Bree K; Sood A; Zhao H; Lobo N; Contieri R; Campbell MT; Guo CC; Navai N; Williams SB; Dinney CP; Kamat AM Urol Oncol; 2023 Feb; 41(2):108.e11-108.e17. PubMed ID: 36404232 [TBL] [Abstract][Full Text] [Related]
14. Limited impact of the COVID-19 pandemic on colorectal cancer care in the Netherlands in 2020. Meijer J; Elferink MAG; Vink GR; Sijtsma FPC; Buijsen J; Nagtegaal ID; Tanis PJ; Wumkes ML; de Hingh IHJT; Siesling S; Int J Colorectal Dis; 2022 Sep; 37(9):2013-2020. PubMed ID: 35986108 [TBL] [Abstract][Full Text] [Related]
15. Evaluating the cost-utility of intravesical Bacillus Calmette-Guérin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK. Grabe-Heyne K; Henne C; Odeyemi I; Pöhlmann J; Ahmed W; Pollock RF J Med Econ; 2023; 26(1):411-421. PubMed ID: 36897006 [TBL] [Abstract][Full Text] [Related]
16. The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer. Doeve BH; Bakx JAC; Siersema PD; Rosman C; van Grieken NCT; van Berge Henegouwen MI; van Sandick JW; Verheij M; Bijlsma MF; Verhoeven RHA; van Laarhoven HWM J Gastroenterol; 2023 Oct; 58(10):965-977. PubMed ID: 37523094 [TBL] [Abstract][Full Text] [Related]
17. The Impact of the COVID-19 Pandemic on Time to Treatment in Surgical Oncology: A National Registry Study in The Netherlands. van Vuren RMG; Janssen YF; Hogenbirk RNM; de Graaff MR; van den Hoek R; Kruijff S; Heineman DJ; van der Plas WY; Wouters MWJM Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730690 [TBL] [Abstract][Full Text] [Related]
18. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Witjes JA; Bruins HM; Cathomas R; Compérat EM; Cowan NC; Gakis G; Hernández V; Linares Espinós E; Lorch A; Neuzillet Y; Rouanne M; Thalmann GN; Veskimäe E; Ribal MJ; van der Heijden AG Eur Urol; 2021 Jan; 79(1):82-104. PubMed ID: 32360052 [TBL] [Abstract][Full Text] [Related]
19. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study. Eijkelboom AH; de Munck L; Larsen M; Bijlsma MJ; Tjan-Heijnen VCG; van Gils CH; Broeders MJM; Nygård JF; Lobbes MBI; Helsper CW; Pijnappel RM; Strobbe LJA; Wesseling J; Hofvind S; Siesling S; Cancer Epidemiol; 2023 Dec; 87():102481. PubMed ID: 37897970 [TBL] [Abstract][Full Text] [Related]
20. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis. Peacock HM; Tambuyzer T; Verdoodt F; Calay F; Poirel HA; De Schutter H; Francart J; Van Damme N; Van Eycken L ESMO Open; 2021 Aug; 6(4):100197. PubMed ID: 34474811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]